Abstract
Background
Implementation of a standardized language in Nursing Care Plans (SNCP) allows for increased efficiency in nursing data management. However, the potential relationship with patientś health outcomes remains uncertain. The aim of this study was to evaluate the effectiveness of SNCP implementation, based on North American Nursing Diagnosis Association (NANDA) and Nursing Interventions Classification (NIC), in the improvement of metabolic, weight, and blood pressure control of Type 2 Diabetes Mellitus (T2DM) patients.
Methods
A two-year prospective follow-up study, in routine clinical practice conditions. 31 primary health care centers (Spain) participated with 24,124 T2DM outpatients. Data was collected from Computerized Clinical Records; SNCP were identified using NANDA and NIC taxonomies. Descriptive and ANCOVA analyses were conducted.
Results
18,320 patients were identified in the Usual Nursing Care (UNC) group and 5,168 in the SNCP group. At the two-year follow-up, the SNCP group improved all parameters except LDL cholesterol and diastolic blood pressure. We analyzed data adjustming by the baseline value for these variables and variables with statistically significant differences between groups at baseline visit. Results indicated a lowering of all parameters except HbA1c, but a statistically significant reduction was only observed with diastolic blood pressure results. However, the adjusted reduction of diastolic blood pressure is of little clinical relevance. Greater differences of control values for diastolic blood pressure, HbA1c, LDL-cholesterol and Body Mass Index were found in the SNCP group, but only reached statistical significance for HbA1c. A greater proportion of patients with baseline HbA1c ≥7 decreased to <7% at the two-year follow-up in the SNCP group than in the UNC group (16.9% vs. 15%; respectively; p = 0.01).
Conclusions
Utilization of SNCP was helpful in achieving glycemic control targets in poorly controlled patients with T2DM (HbA1c ≥7%). Diastolic blood pressure results were slightly improved in the SNCP group compared to the UNC group.
Trial Registration
ClinicalTrials.gov NCT01482481
Introduction
Type 2 Diabetes Mellitus (T2DM) is a chronic disease that has increased its prevalence and incidence rates in recent years [1], and some authors consider it the most important epidemic of the 21st century [2]. It is also associated with premature morbidity and mortality [3], [4] as well as with an increase in healthcare costs [5].
Glycated hemoglobin (HbA1c) is an important indicator of diabetic control, because it provides an average of all the blood glucose readings for the previous two-three months [6]. Several studies [7]–[9] have shown a relationship between the lack of glycemic control (HbA1c>7%) and chronic complications, so the relative risk for stroke or coronary heart disease is 1.18 for each 1-percent point increase in HbA1c (95% Confidence Interval [95% CI] = 1.10–1.26) in patients with T2DM [10].
Currently, the responsibility for the care of patients with diabetes has shifted to a primary health care setting, and, more specifically, to nurses. They have a central role in the treatment of patients with T2DM and have been implementing a wide range of interventions aimed at improving the provision of diabetes care and achieving better metabolic control [11].
In the last decade, there has been enormous development in the implementation of standardized languages in Nursing Care Plans (SNCP) for nursing diagnoses (North American Nursing Diagnosis Association -NANDA) [12] and interventions (Nursing Interventions Classification -NIC) [13]. In Spain since 1998, these taxonomies have been progressively incorporated into normal clinical practice and Computerized Clinical Records (CCR). However, there is still no common language in Spanish nursing practice [14].
The implementation of SNCP care plans allow for increased practicality and efficiency in nursing data management [15], but the potential relationship between nursing interventions and patientś health outcomes remains uncertain [16], [17].
The aim of the study was to evaluate the effectiveness of implementing SNCP in CCR registration in the improvement of metabolic, weight, and blood pressure control of patients with T2DM after two–year follow-up. The SNCP followed NANDA and NIC taxonomies.
Methods
Design
A two-year prospective follow-up study, carried out during the period from March 2008 to February 2010.
Sample
24,124 T2DM patients were potentially eligible to be included in the study. These patients were identified using the CCR and were comprised of patients who regularly visit (at least two records in the CCR over the past year) the 31 primary health care centers in the northeastern urban area of Madrid, Spain.
Eligibility criteria for patients were: over 30 years of age, with previously diagnosed T2DM (cardinal clinical, plus random blood glucose >200 mg/dl or oral glucose of >200 mg/dl at 2 h, twice or plasma fasting glucose of >126 mg/dl on two occasions or previously diagnosed). Patients were not included if they met any of the following exclusion criteria: gestational diabetes, patients involved in clinical trials, patients with life expectancy of less than one year (according to clinical judgment), and homebound patients. Figure 1 show the flowchart of the study.
Figure 1. Flow diagram of participants.
PCHC: Primary Health Care Center; T2DM: Type 2 Diabetes Mellitus; SNCP: Standardized Nursing Care Plans; UNC: Usual Nursing Care; CCR: Computerized Clinical Records; BP: Blood Pressure; HbA1c: Glycated hemoglobin; LDLc: Low-density lipoprotein cholesterol; BMI: Body Mass Index.
During February 2006- February 2008, the vast majority of nurses in the primary health care centers were trained in diagnostic reasoning based on NANDA and NIC taxonomies. Training consisted of eight classes of two hours, taught by a specialized nurse. 94.12% of nurses in the SNCP group and 24.39% of nurses in the UNC group attended the training. The implementation of NANDA and NIC taxonomies in the CCR by primary health care centers in Madrid began in March 2008.
Based on the types of nursing actions registered in the CCR, two groups of nurses were identified: those that used usual nursing care (UNC) and those that used SNCP.
The first group applied UNC which is defined as: direct nursing care, non standardized clinical interventions that contribute to the health or recovery of a patient. UNC for patients with T2DM are defined as: the treatment and monitoring of T2DM including interventions at different levels such as: controlling blood sugar levels, control of cardiovascular risk factors, drug therapy compliance, change in lifestyles, health education, and self-management [18]. UNC were identified in the CCR based on the non-standardized languages in nursing care or the standardized nursing cares based on other taxonomies.
The second group, SNCP group, applied UNC for patients with T2DM and SNCP based on NANDA and NIC taxonomieś. A SNCP describes the care to be provided to a specific group of patients and contains a diagnostic statement, nursing goals, implementation and evaluation [19]; based on up-to-date, evidence-based knowledge.
In the CCR, SNCP was identified based on the following three criteria:
- Criterion 1. The patient has a code that corresponds to the Gordon’s functional health patterns [20] in at least one of the following areas: health perception and health management; nutritional and metabolic; and activity and exercise.
- Criterion 2. The problems identified were described using codes nursing diagnosis statements based on NANDA taxonomy, used in T2DM patients (Table 1). A nursing diagnosis based on NANDA taxonomy is defined as a clinical judgment about individual, family or community responses to actual or potential health problems or life processes which provide the basis for the selection of nursing interventions to achieve patientś outcomes, for which, the nurse is accountable [12].
Table 1. Nursing diagnoses: domains, class, and titles.
| Domain | Class | Nursing diagnoses | |
| Nutrition | Ingestion | 00001 | Imbalanced nutrition: more than body requirements |
| 00002 | Imbalanced nutrition: less than body requirements | ||
| 00003 | Risk for imbalanced nutrition: more than body requirements | ||
| Coping/stress tolerance | Coping responses | 00069 | Ineffective coping |
| Life Principles | Value/Belief/Action Congruence | 00079 | Non compliance |
| Health promotion | Health management | 00078 | Ineffective self health management |
| 00080 | Ineffective family therapeutic Regimen Mangament | ||
| 00081 | Ineffective therapeutic regimen management | ||
| 00082 | Effective therapeutic regimen management | ||
| 00162 | Readiness for enhanced self-health management | ||
| 00163 | Readiness for enhanced nutrition | ||
| 00084 | Health-Seeking Behaviors: Management DM | ||
| Self Perception | Self-Esteem | 00120 | Situational Low self-esteem |
| Perception/cognition | Cognition | 00126 | Deficient knowledge |
| Activity/Rest | Activity/Exercise | 00168 | Sedentary Lifestyle |
| Safety/Protection | Physical injury | 00046 | Impaired skin integrity |
- Criterion 3. The nursing intervention carried out was registered according to the codes of NIC taxonomy, used in T2DM patients [13] (Table 2).
Table 2. Nursing interventions: domains, class, and titles.
| Domain | Class | Nursing interventions | |
| Physiological: Basic and Complex | Activity and exercise management | 0200 | Exercise promotion |
| 1020 | Diet Staging | ||
| 1030 | Eating Disorders: Management | ||
| 1100 | Nutrition Management | ||
| 1160 | Nutritional Monitoring | ||
| 1240 | Weight gain assistance | ||
| 1260 | Weight Management | ||
| 1280 | Weight Reduction Assistance | ||
| 5246 | Nutritional Counseling | ||
| Self-Care Facilitation | 1803 | Self-Care Assistance: Feeding | |
| Electrolyte and Acid-Base Management | 2120 | Hyperglycemia management | |
| 2130 | Hypoglycemia management | ||
| Behavioral | Behavioral Therapy | 4360 | Behavior Modification |
| 4410 | Mutual Goal Setting | ||
| 4420 | Patient Contracting | ||
| 4470 | Self-Modification Assistance | ||
| Cognitive Therapy | 4700 | Cognitive Restructuring | |
| Communication Enhancement | 4920 | Active Listening | |
| Coping assistance | 5210 | Anticipatory Guidance | |
| 5220 | Body Image Enhancement | ||
| 5230 | Coping Enhancement | ||
| 5240 | Counseling | ||
| 5250 | Decision-Making Support | ||
| 5270 | Emotional Support | ||
| 5330 | Mood Management | ||
| 5390 | Self-Awareness Enhancement | ||
| 5400 | Self-Esteem Enhancement | ||
| 5440 | Support System Enhancement | ||
| 5480 | Values Clarification | ||
| Patient education | 5510 | Health Education | |
| 5520 | Learning Facilitation | ||
| 5540 | Learning Readiness Enhancement | ||
| 5602 | Teaching: disease process | ||
| 5606 | Teaching: individual | ||
| 5612 | Teaching: prescribed activity/exercise | ||
| 5614 | Teaching: prescribed diet | ||
| 5616 | Teaching: prescribed medication | ||
| 5618 | Teaching: procedure/treatment | ||
| 5620 | Teaching: psychomotor skills | ||
| Safety | Crisis Management | 6160 | Crisis Intervention |
| Risk management | 6520 | Health Screening | |
| 6610 | Risk Identification | ||
| 6650 | Surveillance | ||
| 6680 | Vital sings monitoring | ||
| Lifespan care | 7140 | Family Support | |
| Health System | Delivery System | 7400 | Health System Guidance |
| 7460 | Patient Rights Protection | ||
| Information Management | 8180 | Telephone Consultation | |
| 8190 | Telephone Follow-up | ||
Sources of Information
The CCR for primary health care in Madrid’s Health Service was used as the data source and was administered by OMI-AP® software. The CCR has been previously validated [21].
Data extraction of patient information was conducted at four time points: baseline, 12 and 18 months and after complete follow-up of the study (two-year follow-up). Data included variables and date on which data had been recorded in the CCR. The collection of variables was performed in routine clinical practice conditions.
For all the patients, the following variables were recorded: sociodemographic (age, gender), clinical variables (diabetes evolution time), personal health habits (smoking: cigarettes/day; drinking: alcohol units/week; physical activity: measured in hours per week with any exercise or activity outside of the patients’ regular job being considered, and recoded as sedentary, moderate-intensity, vigorous-intensity), associated morbidity (hypertension, dyslipidemia, coronary heart disease-CHD), diabetes mellitus complications (retinopathy, nephropathy, neuropathy), and the type of treatment prescribed (pharmacological and dietary). Additionally, biochemical–biological parameters were collected: body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, and HbA1c. Only patients with laboratory values and anthropometric records in the CCR at baseline and at final visit were included to determine the effect of SNCP and achievement of control objectives. In some cases, loss of data was close to 50% (LDL cholesterol).
Blood pressure was measured according to the recommendations of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2003) [22]; these recommendations were the most current at the start of this study.
The primary outcomes were those related to diabetes targets: glycemic control (HbA1c<7), blood pressure control (SBP<130 mm Hg, DBP<80 mmHg), lipid control (LDL cholesterol <130 mg/dl), and weight control (BMI<30 kg/m2) after the two-year follow-up.
The study was approved by the Institutional Review Board of the Committee on Human Research of the Hospital Ramón y Cajal (Madrid). The Committee for the Protection of Human Subjects determined that no informed consent was necessary in this type of study.
Statistical Analysis
First, a descriptive analysis was carried out for each variable included in this study, involving the mean and standard deviation for the quantitative variables and frequencies measured for the qualitative variables. Student’s t-test, or its nonparametric equivalent, was used for paired data (Wilcoxon test). Furthermore, the Pearson χ2 test was used for qualitative variables, and McNemar’s test was used for paired data.
Change (mean at the two-year follow-up value − mean baseline value) was calculated in both groups for the following variables: LDL cholesterol, HbA1c, SBP, DBP, and BMI. The variable Effect of the SNCP was determined for these variables using the formula: mean value of the change in SNCP− mean value of the change in UNC. Covariance analysis methodology (ANCOVA) proposed by Vickers was used to determine the adjusted effect of SNCP [23]. The covariables (adjustment variables) were: the baseline value for these variables and variables with statistically significant differences between groups at baseline visits (age, drinking, physical activity – sedentary, BMI, and type of treatment) or clinical relevance (gender). In order to adjust for significantly different variables at baseline and between both groups multivariate techniques (ANCOVA, logistic regression) were performed in order to adjust by variables imbalanced at baseline values between both groups.
In all instances, the accepted level of significance was 0.05 or less, with 95% CI. All the analyses were carried out using the intention-to-treat principle. Statistical analysis of the data was carried out with SPSS 17.0 (SPSS, Inc., Chicago, Illinois, USA).
Results
A total of 23,488 patients were included, of which 51.6% were female, mean age 69.7 years (SD = 14.5), and mean diabetes evolution time of 8.1 years (SD = 8.3). 18,320 patients were identified as part of the UNC group and 5,168 were identified as part of the SNCP group.
Table 3 show baseline characteristics of the study population. The two groups were homogeneous in gender, but not in age, and diabetes evolution time. Patients in the SNCP group had a higher prevalence of poorer personal health habits (drinking and sedentary physical activity), dyslipidemia and complications (retinopathy). Patients in the SNCP group also received more treatment for diabetes (oral antidiabetic and insulin) and for cardiovascular disease (ARB/calcium antagonist/statins/antiplatelets), with poorer HbA1c (7.25% vs. 7.12%; p<0.001), and better LDL cholesterol (115 mg/dl vs. 119 mg/dl; p<0.001), than patients of the UNC group.
Table 3. Baseline characteristics of the study population.
| UNC (n: 18,320) | SNCP (n: 5,168) | p value | |
| Sociodemographic variables | |||
| Female gender (%) | 51.5 | 52.3 | 0.299 |
| Age (yr) [mean ±SD] | 69±12 | 70±13 | 0.000 |
| Clinical variables | |||
| Diabetes evolution time (yr) [mean ±SD] | 7.4±6.3 | 8.6±6.9 | 0.000 |
| Personal health habits | |||
| Smoking (%) | 19.4 | 18.7 | 0.268 |
| Drinking (%) | 20.9 | 23.4 | 0.000 |
| Physical activity (sedentary) (%) | 1.8 | 4.1 | 0.000 |
| Biological parameters | |||
| BMI (Kg/m2) [mean ±SD] | 30.1±5 | 29.8±4.7 | 0.004 |
| DM treatment profile % | |||
| Drug-free | 11.3 | 8 | 0.000 |
| Oral antidiabetic | 61.5 | 69.8 | 0.000 |
| Insulin | 18.6 | 22.6 | 0.000 |
| Oral antidiabetic + Insulin | 9.6 | 13.4 | 0.000 |
| Others treatments % | |||
| Statins | 47.7 | 52.3 | 0.000 |
| Fibrates | 3.7 | 3.5 | 0.585 |
| Diuretics | 27.9 | 26.5 | 0.054 |
| Beta-blockers | 16.7 | 15.6 | 0.066 |
| Calcium antagonist | 21.1 | 22.5 | 0.031 |
| ACE Inhibitors | 36.2 | 37.3 | 0.135 |
| ARB | 22.6 | 25.2 | 0.000 |
| Antiplatelet | 58.0 | 62.7 | 0.000 |
| Associated morbidity % | |||
| CHD | 13.3 | 13.2 | 0.949 |
| Dyslipidemia | 44.8 | 49.2 | 0.000 |
| Hypertension | 69.6 | 68.6 | 0.160 |
| Complications % | |||
| Retinopathy | 3.5 | 4.5 | 0.001 |
| Nephropathy | 6.8 | 7.1 | 0.351 |
| Neuropathy | 1.8 | 1.7 | 0.947 |
UNC: Usual Nursing Cares; SNCP: Standardized Nursing Care Plans; DM: Diabetes mellitus; BMI: Body mass index; ACE: Angiotensin-converting enzyme; ARB: Angiotensin receptor blockers; CHD: Coronary heart disease.
At the two-year follow-up, both groups experienced a modest decline in their parameter values (Table 4). The unadjusted effect of SNCP improved health outcomes, except for with LDL cholesterol and DPB. After adjusting for baseline parameter values and age, sex, type of treatment and physical inactivity, a lowering effect on all health outcomes was observed except for HbA1c. A statistically significant reduction was only observed with DBP. However, the reduction of DBP was of little clinical relevance.
Table 4. Mean values (SD) and changes of baseline and final parameters in both groups.
| SNCP | UNC | Unadjusted SNCP effect (95% CI) | Adjusted SNCP effect(95% CI) | |
| Hba1c (%) mean (SD) | ||||
| N patients | 3,166 | 9,645 | ||
| Baseline | 7.25 (1.2) | 7.12 (1.2) | ||
| Final | 7.02 (1.1) | 6.92 (1.1) | ||
| Change | −0.23 (1.1) | −0.20 (1.1) | −0.02 (0.02–0.07) | 0.03 (−0.01–0.06) |
| p value | 0.26 | 0.14 | ||
| LDL Cholesterol (mg/dl) mean (SD) | ||||
| N patients | 2,919 | 8,843 | ||
| Baseline | 115 (31) | 119 (33) | ||
| Final | 108 (30) | 111 (31) | ||
| Change | −7.14 (30) | −8.04 (32) | 0.90 (2.22–0.42) | −0.68 (−1.76–0.39) |
| p value | 0.18 | 0.21 | ||
| SBP (mmHg) mean (SD) | ||||
| N patients | 4,354 | 13,680 | ||
| Baseline | 134 (16) | 134 (17) | ||
| Final | 132 (15) | 132 (15) | ||
| Change | −1.95 (19) | −1.48 (18) | −0.46 (−1.08–0.16) | −0.07 (−0.56–0.42) |
| p value | 0.15 | 0.78 | ||
| DBP (mmHg) mean (SD) | ||||
| N patients | 4,354 | 13,680 | ||
| Baseline | 76 (10) | 76 (10) | ||
| Final | 75 (9) | 74 (9) | ||
| Change | −1.45 (11) | −1.46 (11) | 0.01 (0.37–0.36) | −0.33 (−0.63–0.04) |
| p value | 0.98 | 0.02 | ||
| BMI (Kg/m2) mean (SD) | ||||
| N patients | 3,395 | 8,600 | ||
| Baseline | 29.8 (4.7) | 30.1 (5) | ||
| Final | 29.5 (4.7) | 29.8 (5) | ||
| Change | −0.22 (1.9) | −0.22(1.8) | −0.00 (−0.08–0.07) | −0.02 (−0.10–0.05) |
| p value | 0.99 | 0.54 |
UNC: Usual Nursing Cares; SNCP: Standardized Nursing Care Plans; Hba1c: Glycated hemoglobin; LDL: Low-density lipoprotein; SBP: Systolic Blood Pressure; DBP: Diastolic blood pressure; BMI: Body mass index.
Table 5 shows the proportion of patients who achieved the target of glycemic, blood pressure, lipid and weight control, at baseline, 12, 18 and 24 months, in both groups. There was a significant improvement (p<0.01) in the percentage of subjects who complied with control targets in both groups, at the two-year follow-up. The SNCP group showed greater change in control values than the UNC group, in DBP, HbA1c, LDL cholesterol and BMI, but only reached statistical significance for HbA1c. The UNC group performed better than the SNCP group in the degree of control of SBP (p<0.01).
Table 5. Percentage of subjects on-target for cardiovascular risk factors at baseline and at the two-year follow-up, stratified by group (UNC/SNCP).
| N | Baseline (%) | 12 Months (%) | 18 Months (%) | 24 Months (%) | p-value* | Change (%) | p-value | |
| SBP<130 mmHg | ||||||||
| UNC (%) | 13,680 | 31.6 | 33.5 | 35.6 | 35.5 | <0.01 | 3.9 | <0.01 |
| SNCP (%) | 4,354 | 31.6 | 32.9 | 35.5 | 34.5 | <0.01 | 2.9 | |
| DBP<80 mmHg | ||||||||
| UNC (%) | 13,680 | 50.6 | 53 | 55.7 | 55.9 | <0.01 | 5.3 | 0.31 |
| SNCP (%) | 4,354 | 53.7 | 57 | 59.7 | 59.4 | <0.01 | 5.7 | |
| HbA1c <7% | ||||||||
| UNC (%) | 9,645 | 54.4 | 59.2 | 61.2 | 60.3 | <0.01 | 5.9 | <0.01 |
| SNCP (%) | 3,166 | 47.6 | 51.8 | 56.4 | 55.2 | <0.01 | 7.6 | |
| LDL c <130 mg/dl | ||||||||
| UNC (%) | 8,843 | 29.8 | 32.3 | 36.1 | 38.0 | <0.01 | 8.2 | 0.61 |
| SNCP (%) | 2,919 | 33.4 | 34.9 | 38.2 | 41.9 | <0.01 | 8.5 | |
| BMI <30 Kg/m2 | ||||||||
| UNC (%) | 8,600 | 54.2 | 54.8 | 56.3 | 56.6 | <0.01 | 2.4 | 0.21 |
| SNCP (%) | 3,395 | 56.8 | 58.2 | 59.6 | 59.6 | <0.01 | 2.8 |
p*: p value of comparison of the two-year follow-up and baseline values, intragroup differences; Change: Final value (two-years)– Baseline values; UNC: Usual Nursing Cares; SNCP: Standardized Nursing Care Plans; SBP: Systolic Blood Pressure; DBP: Diastolic blood pressure. HbA1c: Glycated hemoglobin; LDL c: Low-density lipoprotein cholesterol; BMI: Body mass index.
There was a greater proportion of patients with baseline HbA1c ≥7 who decreased this value below 7% at the two-year follow-up in the SNCP group that in the UNC group (16.9% vs. 15%, respectively; p<0.01).
Finally, table 6 shows the factors associated with achieving glycemic control in patients with baseline HbA1c ≥7%. After adjusting by type of treatment, age and gender, the SNCP group showed a favourable trend toward target control (OR = 1.11; 95%CI = 0.99–1.24; p: 0.06). The variable more strongly associated with glycemic control was oral antidiabetic agents (OR = 2.41; 95% CI = 2.12–2.75; p<0.01).
Table 6. Associated factors with HbA1c <7% in 12,800 DM patients with baseline HbA1c≥7%: logistic regression model.
| Variables | Adjusted OR | 95% CI | p value |
| Group (SNCP/UNC) | 1,11 | 0,99–1,24 | 0,06 |
| Insulin treatment (yes/no) | 1,20 | 1,06–1,36 | <0,01 |
| Oral antidiabetic agents (yes/no) | 2,41 | 2,12–2,75 | <0,01 |
| Gender (male/female) | 1,16 | 1,05–1,28 | <0,01 |
| Age, yr | 0,99 | 0,98–1 | 0,17 |
UNC: Usual Nursing Cares; SNCP: Standardized Nursing Care Plans; HbA1c: Glycated hemoglobin.
In the SNCP group, average use of NANDA taxonomy in nursing diagnoses was 6.4 (DS = 1.9) and the most frequently used nursing diagnoses included: Effective Therapeutic Regimen Management (33.9%); Ineffective Therapeutic Regimen Management (22.4%); Impaired Skin Integrity (12.3%); Health-Seeking behaviors (9.9%); Imbalanced Nutrition: more than Body Requirements (3.7%); Readiness for Enhanced Self Health Management (3.1%); Deficient knowledge (2.2%) and Non compliance (2%).
Discussion
The present study showed that patients in the SNCP group reached a significant reduction in DBP, at the two-year follow-up, compared to patients in the UNC group. However, a reduction in DBP values has little clinical relevance. SNCP group demonstrated a favourable trend toward the glycemic control in previously poorly controlled patients, after adjusting for age, gender, and type of treatment. The main predictors variables were treatment with oral antidiabetic agents, and insulin treatment; that previously, in our country, had been associated with glycemic control [24].
Preceding studies have shown that the implementation of standardized languages in nursing care plans enhances the quality of documented patient assessments, the identification of commonly occurring diagnoses within similar settings, and coherence among nursing diagnoses, interventions and outcomes [17], [18], but that better documentation did not necessarily lead to better patient care outcomes [17].
Some studies in hospital settings, examined the relationship between the implementation of standardized languages and patient’s outcomes [25], [26]. However, there is a gap in the literature about the potential relationship between the implementation of standardized languages in nursing care plans and health outcomes for chronic patients in primary health care settings [16], [17]. One meta-analysis of nine trials that included 1,846 patients showed limited evidence that standardized electronic documentation of nursing diagnosis and related interventions led to better health outcomes [16].
The utilization of standardized languages in nursing care plans may be interpreted as an organizational intervention aimed at improving the process of care or patient outcomes. In a systematic review [27], which included nine studies of organizational interventions in patients with diabetes, there was no evaluation of the effectiveness of SNCP or nursing diagnoses. For this reason, our study cannot be compared with similar efficacy studies.
The patients in the SNCP group had a greater risk profile. This is consistent with the findings of Paans et al. [28] who identifies that one of the factors associated with the use of nursing diagnoses is the complexity of a patientś situation. For this reason, we adjusted for baseline differences with a multivariate analysis (ANCOVA), in spite of this there is still a possibility of bias in favor of the null hypothesis.
The study sample was composed of patients with T2DM who regularly visited primary health care centers. This may not be representative of the entire T2DM patient community. However, the prevalence of diabetes mellitus recorded in the 31 participating primary health care centers [21] is similar to that found in a population based study carried out in our city [29] (5.02% vs. 6.3%, respectively), so the potential selection bias would be of small magnitude.
Finally, the level of evidence from cohort studies is lower than clinical trials, so our results should be interpreted with caution.
Despite the limitations, this research analyzed a gap in the literature about the unclear relationship between the application of SNCP and patient outcomes. In conclusion, SNCP appears to be helpful in achieving target HbA1c levels in patients with T2DM with previously poorly controlled (HbA1c ≥7%). Other control parameters (blood pressure) are slightly improved compared to UNC. Clinical trials are needed to confirm our findings.
Acknowledgments
We thank the primary health care practitioners who took part in this study.
Funding Statement
Funding for the study was supplied by the “Instituto de la Salud Carlos III” (PI07/0865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. González EL, Johansson S, Wallander MA, García LA (2009) Trends in the prevalence and incidence of diabetes in the UK: 1996–2005. J. Epidemiol Community Health 63: 332–6. [DOI] [PubMed] [Google Scholar]
- 2. Valdés S, Rojo-Martínez G, Soriguer F (2007) Evolution of prevalence of type 2 diabetes in adult Spanish population. Med Clin (Barc) 129: 352–5. [DOI] [PubMed] [Google Scholar]
- 3. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connoly VM (2001) Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 11: 122–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bianchi C, Miccoli R, Penno G, Del Prato S (2008) Primary prevention of cardiovascular disease in people with dysglycemia. Diabetes Care 31(Suppl. 2), S208–14. [DOI] [PubMed]
- 5. American Diabetes Association (2008) Economic costs of diabetes in the U.S. In 2007. Diabetes Care 31: 596–615. [DOI] [PubMed] [Google Scholar]
- 6. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 351: 1755–62. [DOI] [PubMed] [Google Scholar]
- 7. The Diabetes Control and Complications Trial research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986. [DOI] [PubMed] [Google Scholar]
- 8. UK Prospective Diabetes Study (1998) Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853. [PubMed] [Google Scholar]
- 9. Gaede P, Vedel P, Larsen N, Jensen G, Parving H, et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348: 383–393. [DOI] [PubMed] [Google Scholar]
- 10. Selvin E, Marinopoulo,s S, Berkenblit G, Rami T, Brancati FC, et al. (2004) Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141: 421–31. [DOI] [PubMed] [Google Scholar]
- 11. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, et al. (2001) Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care 24(10): 1821–33. [DOI] [PubMed] [Google Scholar]
- 12.NANDA-International (2011) Nursing diagnosis: Definitions and classification 20012–2014. Iowa: Wiley-Blackwell, Ames.
- 13.Bulechek GM, Butcher H, Dochterman JM (2009) Nursing Interventions Classification (NIC) (5th ed.). St Louis: Mosby.
- 14.González-Jurado MA (2006) Normalización de la práctica enfermera como contribución a la salud, la calidad asistencial y la seguridad clínica de las personas. Evaluación en los cuidados del paciente neumológico [Tesis]. Madrid: Universidad Complutense de Madrid. Facultad de Medicina; 2006.
- 15. Lavin MA, Avant K, Craft-Rosenberg M, Herdman TH, Gebbie K (2004) Contexts for the study of the economic influence of nursing diagnoses on patient outcomes. Int J Nurs Terminol Classif. 15(2): 39–47. [DOI] [PubMed] [Google Scholar]
- 16. Urquhart C, Currell R, Grant MJ, Hardiker NR (2009) Nursing record systems: effects on nursing practice and healthcare outcomes. Cochrane Database Syst Rev. 21(1): CD002099. [DOI] [PubMed] [Google Scholar]
- 17. Müller-Staub M, Lavin M A, Needham I, van Achterberg T (2006) Nursing diagnoses, interventions and outcomes – application and impact on nursing practice: systematic review. Journal of Advanced Nursing 56: 514–31 doi: 10.1111/j.1365–2648.2006.04012.x. [DOI] [PubMed] [Google Scholar]
- 18.Estrategia en diabetes del Sistema Nacional de Salud. Sanidad 2007. Ministerio de Sanidad y Consumo. Available: http://www.msc.es/organizacion/sns/planCalidadSNS/pdf/excelencia/cuidadospaliativos-diabetes/DIABETES/estrategia_diabetes_sistema_nacional_salud.pdf. Accessed 3 April 2012.
- 19.Carpenito LJ (2000) Nursing Diagnosis: Application to Clinical Practice. 8th edn, Lippincott, Philadelphia, PA.
- 20.Gordon M (1994) Nursing Diagnosis: Process and application, Third Edition. St. Louis: Mosby.
- 21. de Burgos-Lunar C, Salinero-Fort MA, Cardenas-Valladolid J, Soto-Diaz S, Fuentes-Rodriguez CY, et al. (2011) Validation of diabetes mellitus and hypertension diagnosis in computerized medical records in primary health care. BMC Med Res Methodol 11: 146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 42: 1206–52. [DOI] [PubMed] [Google Scholar]
- 23. Vickers AJ, Altman DG (2001) Analysing controlled trials with baseline and follow up measurements. BMJ 323: 1123–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Díaz GJ, Palmeiro G, Casado I, Arandia M, Portuburu MM, et al. (2006) Cumplimiento de los objetivos de control metabólico en diabetes mellitus en el medio rural de ourense. Rev Esp Salud Publica 80: 67–75. [DOI] [PubMed] [Google Scholar]
- 25.Welton JM, Halloran EJ (1999) A comparison of nursing and medical diagnoses in predicting hospital outcomes. Proc AMIA Symp 171–5. [PMC free article] [PubMed]
- 26. Rosenthal GE, Halloran EJ, Kiley M, Pinkley C, Landefeld CS (1992) Development and validation of the nursing severity index: a new method for measuring severity of illness using nursing diagnoses. Medical Care 30: 1127–41. [DOI] [PubMed] [Google Scholar]
- 27. Renders CM, Valk GD, Griffin SJ, Wagner EH, Ejik JT, et al. (2001) Interventions to improve the management of diabetes in primary care, outpatient, and community settings. Diabetes Care 24: 1821–33. [DOI] [PubMed] [Google Scholar]
- 28. Paans W, Nieweg RM, van der Schans CP, Sermeus W (2011) What factors influence the prevalence and accuracy of nursing diagnoses documentation in clinical practice? A systematic literature review. J Clin Nurs 20: 2386–2403. [DOI] [PubMed] [Google Scholar]
- 29.Gil Montalbán E, Zorrilla Torras B, Ortiz Marrón H, Martínez Cortés M, Donoso Navarro E, et al. (2010) Prevalence of diabetes mellitus and cardiovascular risk factors in the adult population of the autonomous region of Madrid (Spain): the PREDIMERC study. Gac Sanit 24(3): 233–40. Epub 2010 Apr 8. [DOI] [PubMed]